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Abstract: Skin irritation is a complex phenomenon, and keratinocytes play an important role in it. We have recently char-
acterized the expression and protective role of adipose differentiation related protein (ADRP) in skin irritation. In particular, 
ADRP expression is induced to recover functional cell membrane following the cell damage caused by skin irritants.
The purpose of this study was to characterize in a human keratinocyte cells line (NCTC 2544) the biochemical events 
that lead to ADRP expression following SDS treatment, and in particular, to investigate the role of transcription factor SP-1. 
Analysis of ADRP promoter region revealed the presence of a potential binding site for the transcription factor SP-1 close 
to the start site. Evaluated by measuring the DNA binding activity, we found that SDS induced a dose and time related SP-1 
activation, which was correlated with SDS-induced ADRP mRNA expression. Furthermore, SDS-induced SP-1 activation, 
ADRP mRNA expression and lipid droplets accumulation could be modulated by mithramycin A, an antibiotic that selec-
tively binds to the GC box preventing SP-1 binding and gene expression. This demonstrated that SDS-induced ADRP 
expression was mediated in part through the transcription factor SP-1. In addition, SDS-induced SP-1 activation and ADRP 
expression could be modulated by the calcium chelator BAPTA, indicating a role of calcium in ADRP-induction.
Thus, every time an irritant perturbs the membrane barrier, it renders the membrane leaky and allows extracellular cal-
cium to enter the cells, an event that provides the upstream mechanisms initiating the signaling cascade that triggers the 
activation of SP-1 and culminates in the enhancement of ADRP expression, which helps to restore the normal homeostasis 
and ultimately repairs the to membrane.
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Introduction
Skin irritation is, from both a clinical and a mechanistic perspective, a multifaceted disease. The bio-
chemical mechanisms activated in contact dermatitis are complex and not fully understood, normally 
involving resident epidermal cells and ﬁ  broblasts of dermis, as well as, invading leukocytes, interacting 
with each other under the control of a network of cytokines and lipid mediators (Boss and Kapsenberg, 
1993; Corsini and Galli, 1998; 2000). In the last two decades, it has become clear that keratinocytes, 
which represent 95% of epidermal cells, play an important role in initiating and maintaining skin inﬂ  am-
matory and immunological reactions. Using genomic techniques, we have identiﬁ  ed in human 
keratinocytes the upregulation of adipose differentiation related protein (ADRP) by skin irritants (Corsini 
et al. 2002). ADRP, the human homolog has been termed adipophilin, is a 53 kDa protein initially cloned 
from a differentiated murine adipocyte cDNA library (Jiang and Serrero, 1992). ADRP is a lipid drop-
let protein found in most cells and tissues, which has an important role in management of neutral lipid 
stores, both in deposition and mobilization (Heid et al. 1998). Intracellular neutral lipid storage droplets 
are essential cytosolic organelles of eukaryotic cells used mainly as energy source and for membrane 
biogenesis (Brasaemle et al. 1997; Miura et al. 2002). Lipid droplets provide fatty acids for signaling/
gene regulation, fatty acids and glycerides for membrane phospholipid synthesis, as well as, fatty acids 
to produce energy (Brown, 2001).
Following ultrastructural examination, both in physiological and pathological conditions, the pres-
ence of neutral lipid droplets in keratinocytes has been occasionally described (Johnson et al. 1987; 
Kanerva, 1990; El-Shoura and Tallab, 1997). In physiological conditions, lipids are synthesized by 
keratinocytes and exported to the intercellular space to form the skin permeability barrier. On the 208
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contrary, the presence of numerous lipid droplets 
in the horny cells is a marker of abnormal kerati-
nization and/or of a hyperproliferative effect.
Exposure of normal skin to organic solvents or 
detergents removes lipids affecting the barrier 
integrity, often induces irritant contact dermatitis 
(Imokawa et al. 1989; Grubauer et al. 1989). The 
disruption of the barrier function by lipid extraction 
is followed by a burst of epidermal lipid synthesis, 
including unsaponiﬁ  able lipids, fatty acids and 
sphingolipids to restore their normal level and bar-
rier functions (Menon et al. 1985; Grubauer et al 
1989; Holleran et al. 1991).
We have previously demonstrated the up-
regulation of ADRP in human keratinocytes by 
skin irritants, and we have also showed its protec-
tive role in SDS-induced cell damage (Corsini et al. 
2003). ADRP expression was also induced in vivo 
in an experimental model of skin irritation, con-
ﬁ  rming the relevance of the in vitro model of 
irritancy (Corsini et al. 2003). We have proposed 
the following scenario: the surfactant effect of SDS 
damages lipid bilayers of cell membranes, render-
ing them leaky and allowing extracellular calcium 
entrance and activation of gene expression, includ-
ing ADRP. Lipids deriving from damaged mem-
brane are then reorganized into lipid droplets by 
ADRP and eventually reused to repair membrane. 
In parallel, disruption of the cell membrane leads 
to the release of proinﬂ  ammatory cytokines, such 
as interleukin-1α, which in turn by acting in an 
autocrine manner may induce tumor necrosis 
factor-α, IL-8 and other inﬂ  ammatory mediators 
release, resulting in skin irritation.
The analysis of 540 bp of 5′-ﬂ  anking region of 
mouse ADRP gene for potential transcription fac-
tors binding sites revealed consensus sequences 
for SP-1, TRE, AP-2, NF-1, c-myc, Pax-2, two 
TRE half-sites, and a close match to EGR1 and 
WT1 (Eisinger and Serrero, 1993). However, little 
is known about the molecular mechanisms and 
promoter control elements, those regulate the tran-
scription of the human ADRP gene. As in the 
mouse promoter region, the bioinformatic analysis 
of the 5′-ﬂ  anking region of exon 1 of the human 
ADRP gene, revealed the presence of two potential 
binding sites for the transcription factor SP-1 close 
to the start site (in position −42 and −58). The 
purpose of this study was to conduct molecular 
mechanistic investigations and aimed to character-
ize the role of transcription factor SP-1 in SDS-
induced ADRP expression in human keratinocytes. 
This is the ﬁ  rst report of the role of SP-1 activation 
in the regulation of ADRP expression in human 
keratinocytes by skin irritants, offering insight into 
the mechanisms which serve to regulate ADRP 
transcription.
Materials and Methods
Chemicals
1,2-bis(2-aminophenoxyethane-N,N,N′, 
N′-tetraacetic acid acetoxymethyl ester (BAPTA), 
fura-2 pentakis(acetoxymethyl) ester (FURA 2-AM), 
nile red (9-diethylamino-5H-benzophenoxazine-
5-one), 12-O-tetradecanoylphorbol 13-acetate 
(TPA) and sodium dodecyl sulfate (SDS) were 
obtained from Sigma (St Louis, MO, U.S.A.). 
Mithramycin was from Tocris (Bristol, U.K.). 
Antibodies against human ADRP FITC-conjugated 
were obtained from Research Diagnostic Inc. 
(Flanders, NJ, U.S.A.). Electrophoresis reagents 
were from Bio-Rad (Richmond, CA, U.S.A.). All 
other reagents, unless speciﬁ  ed, were purchased 
from Sigma. All reagents were purchased at the 
highest purity available.
Cells and experimental procedures
The human epidermal cell line NCTC 2544 (ICN 
Flow, Irvine, U.K.) was cultured in RPMI 1640 
(Sigma) containing 2 mM L-glutamine, 0.1 mg/ml 
streptomycin, 100 IU/ml penicillin (media), and 
supplemented with 10% fetal calf serum (FCS, 
Sigma), at 37 °C in 5% CO2. For the majority of 
experiments, cells were cultured to conﬂ  uence in 
12 well plates. Conﬂ  uent monolayers contained 
approximately 2 × 10
6 cells. Then, cells were incu-
bated for different times in the presence or absence 
of SDS or other compounds in 0.56 ml of media 
supplemented with 1% FCS, as indicated in the 
legend to ﬁ  gures.
To assess the involvement of SP-1, cells were 
treated for 1 h with the speciﬁ  c SP-1 inhibitor 
mithramycin or DMSO as vehicle control (ﬁ  nal 
concentration 0.2%) in media supplemented with 
1% FCS; then exposed to SDS for different times 
as indicated in the ﬁ  gure legends.To characterize 
the role of calcium, cells were incubated with the 
calcium chelator BAPTA (30 µM) for 30 min in 
media supplemented with 1% FCS. Monolayers 
were then washed once and cells were cultured 
with SDS for different time points.209
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Transcription factor activation
Nuclear extract were prepared essentially as 
described by Schreiber et al. (1989). After treatment, 
cells were lysed in 0.4 ml of a hypotonic lysis 
buffer (10 mM Hepes, pH 7.8, 10 mM KCl, 2 mM 
MgCl2, 1 mM dithiothreitol, 0.1 mM EDTA, 0.1 mM 
phenylmethylsulfonyl fluoride). Cells were 
incubated on ice for 15 min and then 25 µl of a 
10% Nonidet P-40 solution was added, and 
cells were mixed for 15 sec, and then centrifuged for 
30 sec at 12,000 rpm. Pelleted nuclei were 
suspended in 50 µl of buffer C (50 mM Hepes, pH 
7.8, 50 mM KCl, 300 mM NaCl, 10% glycerol, 
1 mM dithiothreitol (DTT), 0.1 mM EDTA, 0.1 mM 
phenylmethylsulfonyl ﬂ  uoride), mixed for 20 min, 
and centrifuged for 5 min at 12,000 rpm. The 
supernatants represented the nuclear extracts. 
Protein concentration was measured using a com-
mercial kit (Bio-Rad). SP-1 activation was evaluated 
both by electrophoretic mobility shift assay (EMSA) 
as previously described (Corsini et al. 2001), and by 
a speciﬁ  c colorimetric method using a commercially 
available kit (BD Mercury TransFactor kit, BDBio-
sciences, San Jose, CA, U.S.A.). Briefly, the 
TransFactor kit is a 96-well plate with oligonuclo-
etides containing the consensus binding sequence 
for each transcription factors coated on the wells. 
When cell extracts containing the transcription 
factors are incubated in the wells, the transcription 
factors bind to their consensus sequences. Bound 
transcription factors are then detected by a 
speciﬁ  c primary antibody. A horseradish peroxidase-
conjugated secondary antibody is then used to detect 
the bound primary antibody. The enzymatic product 
is then measured with standard microtiter 
plate reader. For EMSA, binding reaction mixtures 
(16 µl) containing 5 µg of protein of nuclear extract, 
2 µg of poly (dI-dC)-poly(dI-dC), 10,000 cpm 
of 
32P-labeled probe in binding buffer (10 mM Hepes, 
pH 7.9, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 
10% glycerol, 1% Ficoll, and 0.2 mg/ml albumin) 
were incubated for 30 min at room temperature 
before separation in a 7% acrylamide gel in 1X TBE 
followed by autoradiography. A double-strand 
oligonucleodide containing the binding site for SP-1 
(5′-ATTCGATATCGGGGCGGGGCGAGC-3′) - 
was labeled with α-
32PdATP using T4 poly nucleo-
tide kinase (Amersham, Buckinghamshire, U.K.).
Fluorescence microscopy
Lipid droplets accumulation and ADRP expression 
were analyzed using, nile red and anti human 
ADRP antibody, respectively. Nile red is a vital 
stain for the detection of intracellular lipid droplets 
by ﬂ  uorescence microscopy and ﬂ  ow cytometry 
(Greenspan et al. 1985). After treatment, monolay-
ers were washed twice with PBS, cells were tryp-
sinized, ﬁ  xed in 2% formaldehyde for 20 min at 
room temperature, washed once with PBS, and 
stained with nile red in PBS for 10 min. Nile red 
was dissolved in ethanol at 1 mg/ml and then added 
to PBS to the ﬁ  nal concentration of 10 µg/ml. After 
washing with PBS, cells were resuspended in 
0.5 ml of PBS and a cytospin using 50 µl was done. 
For ADRP staining, cells were ﬁ  xed and permea-
bilized after trypsinisation using Leucoperm
TM, 
following supplier’s instructions (Serotec, Oxford, 
U.K.). Cells were stained for 30 min at room tem-
perature with 1:10 diluted ﬂ  uorescein conjugated 
anti human ADRP. After washing with PBS, cells 
were resuspended in 0.5 ml of PBS and a cytospine 
of 50 µl was performed. In both cases, coverslips 
were mounted on glass slides using Permaﬂ  uor 
(Lipshaw Immunon, Pittsburgh, PA, U.S.A.) and 
cells were observed under a Zeiss ﬂ  uorescence 
microscope equipped with a camera (Zeiss, 
Thornwood, NY, U.S.A.).
Flow cytometric analysis
Cells were stained as described above. The mean 
ﬂ  uorescence of 10,000 events of nile red stained 
cells was measured in the FL2 channel set for log 
scale, while the percentage of ADRP-stained cells 
was measured in the FL1 channel set for log scale, 
using FACScan ﬂ  ow cytometry (Becton Dickinson, 
Italy).
Lactate dehydrogenase
Lactate dehydrogenase (LDH) leakage, as indica-
tor of cell viability and membrane integrity, was 
determined in the culture media using a commer-
cially available kit (Sigma). Results are expressed 
in U/l.
Reverse Transcriptase-Polymerase 
Chain Reaction (RT-PCR)
For determination of ADRP mRNA levels, semi-
quantitative RT-PCR was performed as previously 
described (Corsini et al. 1999). Brieﬂ  y, for time 
course experiments conﬂ  uent cells cultured in 
6 wells plate were treated with SDS (15 µg/ml) 
in 1.4 ml of media supplemented with 1% FCS for 210
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different time points (1–18 h), while to investigate 
the role of SP-1 in ADRP mRNA expression cells 
were treated for 1 h with increasing concentra-
tions of mithramycin (0.01–1 µM) or DMSO as 
vehicle control and, then in the presence or 
absence of SDS (15 µg/ml) for 6 h. Monolayers 
were washed once with PBS and cells lysed in 
1 ml of Trizol
TM (Invitrogen, Carlsbad, CA, 
U.S.A.). Total RNA was extracted following 
supplier’s instructions. PCR primers for ADRP 
and glyceraldheyde-6-phosphate dehydrogenase 
(GPDH) were synthesized and contained the 
following sequences:
– ADRP: sense, 5′-AGCTGTTGGTAGAACAG
        TAC-3′
– ADRP antisense, 5′-AGATGTCGCCTGCCAT
      CACC-3′
– GPDH: sense, 5′-CCACCCATGGCAAATTC
      CATGGCA-3′
– GPDH antisense, 5′-TCTAGACGGCAGGT
        CAGGTCCACC-3′
The ampliﬁ  ed PCR products are 510 bp for 
ADRP and 600 bp for GPDH. In preliminary 
experiments, RNA concentrations and PCR cycles 
were titrated to establish curves to document lin-
earity and to permit semiquantitative analysis of 
signal strength (1 ng for ADRP and 4 ng for 
GPDH). The PCR was conducted using a Perkin 
Elmer thermocycler, with the following conditions: 
28 cycles of denaturation at 95 °C for 30 sec, 
annealing at 60 °C for 30 sec, extension at 72 °C 
for 30 sec, followed by a ﬁ  nal 7 min extension at 
72 °C. Gels were photographed with type 55 ﬁ  lm 
(Polaroid, Cambridge, MA, U.S.A.).
Determination of cytosolic free Ca
2+ 
concentration
Cells grown on a glass coverslip were treated in 
the presence or absence of BAPTA (30 µM) for 
30 min, washed and incubated for 3 h with SDS 
(25 µg/ml). During the last 30 min of incubation, 
cells were loaded with 10 µM FURA2-AM 
(Sigma). At the end of the incubation, cells were 
washed twice and cytosolic calcium was measured 
in HBSS by the intensity of the ﬂ  uorescence emis-
sion at 505 nm upon excitation at 340–380 nm in 
a Perkin Elmer LS 50 B double wavelength spec-
troﬂ  uorimeter. The FURA2 ﬂ  uorescence signal 
was calibrated in terms of [Ca
2+]i as described by 
Grynkiewicz et al. (1985).
Statistical analysis
All experiments were performed at least three 
times, with representative results shown. The data 
presented are expressed as mean ± SD. Statistical 
signiﬁ  cance was determined by Dunnett’s multiple 
comparison test after ANOVA. Differences were 
considered signiﬁ  cant if p  0.05.
Results
Role of SP-1 in SDS-induced 
ADRP expression and lipid droplets 
accumulation
In order to understand the role of transcription 
factor SP-1 in SDS-induced ADRP expression, we 
ﬁ  rst assessed the ability of SDS to induce SP-1 
activation. As shown in Figure 1, SDS induced a 
time (1A) and dose related (1B) SP-1 activation, 
which preceded mRNA accumulation (1C). SDS-
induced SP-1 activation reached a maximum after 
45 min, and returned to control values after 180 
min (Fig. 1A), while SDS-induced ADRP mRNA 
expression started after 1 h of treatment and 
increased thereafter (Fig. 1C).
Mithramycin prevents SDS-induced 
ADRP expression and lipid droplets 
accumulation
To further evaluate the role of SP-1 activation in 
ADRP expression and lipid droplets accumulation, 
we examined whether mithramycin A, an antibiotic 
that selectively binds to GC box preventing SP-1 
binding and subsequent gene expression (Ray 
et al. 1989), could inhibit SDS-induced ADRP 
expression. As evaluated by EMSA (Fig. 2A) and 
by a colorimetric assay (Table 1), treatment with 
mithramycin A prevented in a dose-related manner 
SDS-induced SP-1 activation. Mithramycin also 
prevented ADRP mRNA expression (Fig. 2B), as 
evaluated by semiquantitative RT-PCR, and 
reduced lipid droplets accumulation (Figs. 2C and 
2D), as evaluated by ADPR immunohistochemis-
try and FACS analysis of ADRP positive cells. The 
inhibitory effect of mithramycin A was not due to 
cytotoxicity, as assessed by measuring LDH leak-
age in culture medium, since no cell death was 
observed in cells treated with mithramycin 1 µM 
for up to 18 h (8 ± 5 mU/ml in control vs 6 ± 2 
mU/ml in mithramycin treated cells).211
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Figure 1. SDS induces a dose and time related activation of SP-1. SDS-induced SP-1 activation is consistent with SDS-induced ADRP 
mRNA expression. SP-1 activation was assessed by the colorimetric assay described in the Materials and Methods section. A) Time course. 
Conﬂ  uent cells were treated for different time points (30–180 min) in the presence or absence (control) of SDS 15 µg/ml. B) Dose response. 
Conﬂ  uent cells were treated with increasing concentrations of SDS (0–25 µg/ml) for 45 min. Results are expressed as % of SP-1 activation 
relative to control (untreated cells). Each value represents the mean ±SD of three independent samples. *p  0.05 vs control cells. C) ADRP 
mRNA expression. Conﬂ  uent cells were treated with SDS 15 µg/ml for different times (0–18 h). mRNA expression was evaluated by semi-
quantitative RT-PCR.
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Role of calcium SDS-induced SP-1 
activation and lipid droplets 
accumulation
Under experimental conditions, where SDS-
induced intracellular calcium increase (Fig. 3A) 
was completely prevented by using the intracel-
lular calcium chelator BAPTA (from a 171 ± 14% 
increase to 90 ± 23%), SDS failed to induce SP-1 
activation (Fig. 3B), demonstrating a role of cal-
cium in SP-1 activation. SDS alone induced a 
170 ± 32% increase in SP-1 activation relative to 
control values and the treatment with BAPTA 
completely abolished it (107 ± 3%). Also lipid 
accumulation, as assessed by nile red staining and 
FACS analysis (Fig. 3C), was completely pre-
vented by BAPTA.
Discussion
The purpose of this study was to characterize the 
role of transcription factor SP-1 in SDS-induced 
ADRP expression in human keratinocytes. We 
could show that SDS induces a dose and time 
related SP-1 activation and that mithramycin A, a 
selective SP-1 inhibitor, prevents SDS-induced 
SP-1 activation, ADRP mRNA expression, and 
lipid droplets accumulation.
We focused our attention on SP-1, since a con-
sensus sequence for this transcription factor, close 
to the start site (–45), was found in the 5′-ﬂ  anking 
region of mouse ADRP gene (Eisinger and Serrero, 
1993). Similarly, also in the 5′-ﬂ  anking region of 
exon 1 of the human ADRP gene two potential 
binding sites for the transcription factor SP-1 close 
to the start site (in position –42 and –58) can been 
identiﬁ  ed. We could demonstrate that the activation 
of SP-1 plays a crucial role in SDS-induced human 
ADRP expression.
SP family plays a major role in the expression 
of numerous housekeeping genes, and SP-1, a 
member of this family, is an abundant nuclear 
protein in many cells (Saffer et al. 1991). It has 
been shown that SP-1 is involved in the expression 
of cell cycle regulated genes (Karlseder et al. 
1996). The role of SP-1 in ADRP expression might 
also be relevant in cell proliferation, due the impor-
tant role of ADRP in the management of neutral 
lipid stores, which are essential cytosolic organelles, 
used mainly as energy source and for membrane 
biogenesis.
Overall, little is known about the promoter 
elements, that regulate the transcription of human 
ADRP. A peroxisome proliferators-activated recep-
tor (PPAR) response element has been recently 
identiﬁ  ed within the promoter region of the human 
ADRP gene, that mediates the upregulation of 
transcription in response to agonists of PPAR in 
rat and human hepatocyte-derived cell lines 
(Targett-Adams et al. 2005). Consistently with this 
ﬁ  nding, it has been demonstrated in keratinocytes 
that PPAR-beta/delta activation, aside from stimu-
lating keratinocyte differentiation-related genes, 
improving barrier homeostasis and stimulat-
ing triglycerides accumulation induces ADRP 
(Schmuth et al. 2004). Thus, it is possible that 
SDS-induced membrane damage may liberate 
endogenous lipid metabolites, which in turn may 
activate PPAR or, alternatively, SDS may induce 
PPAR- beta/delta expression. In addition to PPARs, 
in macrophages it has been demonstrated that 
ADRP gene transcription in response to TPA is 
conjointly regulated by transcription factors PU.1 
and AP-1 (Wei et al. 2005).
In the context of skin irritation, we have previ-
ously demonstrated that ADRP expression is induced 
to repair membrane cell damage induced by irritants 
(Corsini et al. 2003). The surfactant effect of SDS 
damages lipid bilayers of cell membranes, rendering 
them leaky and allowing the entrance of extracel-
lular calcium, an event that can trigger the upstream 
mechanisms that initiate the signaling cascade, result 
in the activation of SP-1 and culminates with the 
enhanced ADRP expression. In agreement with the 
scenario described above, we could demonstrate that 
SDS-induced SP-1 activation depends on intracel-
lular calcium increase.
Overall, our findings offer insight into the 
mechanisms, that serve to regulate ADRP expres-
sion and demonstrate that SP-1 site is an important 
cis-acting element regulating its expression.
Table 1. Effect of mithramycin on SDS-induced SP-1 
activation.
Treatment SP-1  activation   
  (% of relative control)
SDS 15 µg/ml 139.0  ± 5.3
Mithramycin 10 nM + SDS  120 ± 5.5
Mithramycin 100 nM + SDS  98.0 ± 16.0*
Mithramycin 1000 nM + SDS  99.8 ± 8.6*
Conﬂ  uent cells were treated with mithramycin (10–1000 nM) for 1 
h and then, in the presence or absence of SDS (15 µg/ml, SDS) 
for 45 min. SP-1 activation was assessed by a colorimetric assay. 
Results are expressed as % of SP-1 activation relative to control. 
Each value represents the mean ± SD of three independent 
samples. *p < 0.05 vs SDS treated cells.213
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Figure 2. Inhibition of SP-1 by mithramycin prevents SDS-induced ADRP expression and lipid droplets accumulation. Conﬂ  uent cells were 
treated with mithramycin (Mitra, 0.01–1 µM) for 1 h and then, in the presence or absence of SDS (15 µg/ml, SDS or +) for different time 
points. A) SP-1 activation evaluated by EMSA. Conﬂ  uent cells were treated with mithramycin 0.1 µM or DMSO as vehicle control for 1 h and 
then SDS 15 µ/ml was added for 45 min. Lane 1, control; lane 2, SDS; lane 3, mithramycin; lane 4 mithramycin plus SDS; lane 5, SDS; lane 
6, SDS plus cold probe. 5 µg of nuclear extract was used, except for competition for which 10 µg of nuclear extract was used. The migration 
position of SP-1 protein-DNA complex and of the unbound probe are indicated. B) ADRP mRNA expression by RT-PCR analysis. Conﬂ  uent 
cells were treated with increasing concentrations of mithramycin 0.01–1 µM or DMSO as vehicle control for 1 h and then SDS 15 µ/ml (+) 
was added for 3 h. mRNA expression was evaluated by semi-quantitative RT-PCR. C) Immunoﬂ  uorescent localization of ADRP. Cells were 
treated in the presence or absence of mithramycin 0.1 µM for 1 h and then +/−SDS for 18 h. Cells were trypsinized, ﬁ  xed and lysed using 
Leucoperm
TM followed by incubation with anti human ADRP antibody FITC conjugated for 30 min at RT. Cells were observed under a ﬂ  uo-
rescence microscope equipped with a camera. D) Flow cytometric analysis of ADRP positive cells. Results are expressed as % of positive 
cells. Each value represents the mean ±SD of 3 independent samples. 
**p  0.01 vs control cells, §§p  0.01 vs SDS treated cells.
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ADRP, adipose differentiation related protein; 
BAPTA, 1,2-bis(2-aminophenoxyethane-N,N,N′, 
N′-tetraacetic acid acetoxymethyl ester; DMSO, 
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ethylenediaminetetraacetic acid disodium 
salt; 2-AM, fura-2 pentakis(acetoxymethyl) ester; 
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Figure 3. Role of calcium in SDS-induced SP-1 activation and lipid droplets accumulation. Conﬂ  uent cells were treated with BAPTA 30 µM 
for 30 min, culture medium was removed, cells washed and then, in the presence or absence of SDS (15 µg/ml) for different times. A) Effect 
of BAPTA on SDS-induced calcium rise. Calcium was measured as described in Materials and Methods section after 3 h of SDS treatment. 
Each value represents the mean ± SD of three independent experiments. B) Effect of BAPTA on SDS (15 µg/ml)-induced SP-1 activation, 
t = 45 min. SP-1 activation was assessed by the colorimetric assay described in the Materials and Methods section. Results are expressed 
as % of SP-1 activation relative to control. C) Effect of BAPTA on SDS (15 µg/ml)-induced lipid droplets accumulation after 18 h of treatment. 
Lipid droplets accumulation was assessed by FACS analysis of nile red stained cells. Results are expressed as nile red mean ﬂ  uorescence 
(mean FL2). 
*p  0.05, **p  0.01 vs relative control cells; §§p  0.01 vs SDS-treated cells.
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